Fig. 3From: Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy – a retrospective study including 32 patientsIllustration of administered chemotherapy regimens. Each row represents an individual patient. The length of the segments indicates the time from onset of the chemotherapy regimen to progression. Censoring and death events are marked by triangles and squares, respectively. Color coding: green = anthracycline, red = anthracycline + DRZ, black = other substance(s). Patients are sorted in ascending order of total administered anthracycline dose. The patient marked by an asterix received adjuvant chemotherapy before start of palliative treatment, which is not represented in the plotBack to article page